Omega 3 fatty acids and the eye

Insight - Journal of the American Society of Ophthalmic Registered Nurses

Volumn 33, Issue 4, 2008, Pages 20-25

  Cakiner Egilmez, Tulay ^a,b  

^a Massachusetts Eye and Ear Infirmary ^*  (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

DRY EYE; HUMAN; RETINA MACULA DEGENERATION; REVIEW; VISUAL DISORDER;

DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MACULAR DEGENERATION; VISION DISORDERS;

EID: 64849090008     PISSN: 1060135X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S., & Vane, J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978; 2(8081):117-19.
2. Brenner, G. M., & Stevens, C. W. Autacoid drugs. In: Pharmacology. Second edition. Saunders, 2000, 293-295.
3. Nadine, M., Zatsick, R., & Mayket, P. Fish Oil: Getting to the Heart of It. Journal for Nurse Practitioners, http://www.medscape.com. Accessed 10.8.2007.
4. Oh, R. Practical applications of fish oil in primary care. Journal of American Board Family Medicine, 2005; 18(1):28-36.
5. Endres, S., Ghorbani, R., Kelly, V. E., et al. The effect of dietary supplementation with n-3 fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med, 1989; 320:265-70.
6. Trebble, T. M., Wootton, S. A., Miles, E. A., et al. Prostaglandin E2 production and T-cell function after fish-oil supplementation: Response to antioxidant co-supplementation. American Journal of Clinical Nutrition, 2003; 78:376-82.
7. Kromhout, D., Bosschieter, E. B., & de Lezenne, C. C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New England Journal of Medicine, 1985; 312:1205-09.
8. Daviglus, M. L., Stamler, J., Orencia, A. J., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med, 1997; 336:1046-53.
9. Hu, F. B., Bronner, L., Willett, W. C., et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. Journal of American Medical Association, 2002; 287:1815-21.
10. Albert, C. M., Campos, H., Stampfer, M. J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med, 2002; 346:1113-18.
11. Hooper, L., Thompson, R. L., & Harrison, R. A. Risks and benefits of omega-3 fats for mortality, cardiovascular disease, and cancer: Systematic review. British Medical Journal, 2006; April 1; 332(7544):752-60.
12. Ness, A. R., Hughes, J., Elwood, P. C., et al. The long-term effect of dietary advice in men with coronary disease: Follow-up of the Diet and Reinfarction Trial (DART). European Journal of Clinical Nutrition, 2002; 56(6):512-18.
13. Fish and omega-3 fatty acids. Retrieved on December 2, 2007, from http://www.americanheart.org/presenter.jhtml?identifier=4632.
14. Burr, M. L., Dunstan, F. D., & George, C. H. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results. Journal of Membrane Biology, 2005; 206(2):155-63.
15. O'Keefe, J. H. Jr., & Harris, W. S. (2000). From Inuit to implementation: Omega-3 fatty acids come of age. Mayo Clinic Proceedings, 2000; 75(6): 607-14.
16. Reiffel, J. A., & McDonald, A. Antiarrhythmic effects of omega-3 fatty acids. American Journal of Cardiology, 2006; 98(4A):50i-60i.
17. Marchioli, R., Levantesi, G., Macchia, A., et al. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial. Journal of Membrane Biology, 2005; 206(2):117-128.
18. Balk, E., Chung, M., Lichtenstein, A., et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evidence Report/Technology Assessment No. 93. AHRQ Publication No. 04-E010-2. Rockville (MD): 2004; Agency for Healthcare Research and Quality.
19. Phillipson, B. E., Rothrock, D. W., Connor, W. E., et al. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med, 1985; 312:1210-16.
20. Contacos, C., Barter, P. J., & Sullivan, D. R. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arteriosclerosis, Thrombosis and Vascular Biology, 1993; 12:1755-62.
21. Durrington, P. N., Bhatnagar, D., Mackness, M. I., et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin-treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart, 2001; 85:544-548.
22. Jacobson, T. A., Miller, M., & Schaefer, E. J. Hypertriglyceridemia and cardiovascular risk reduction. Clinical Therapy, 2007; 29(5):763-77.
23. Yokoyama, M., & Origasa, H. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). American Heart Journal, 2003; 146(4):613-20.
24. Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., et al. Blood pressure response to fish oil supplementation: Meta-regression analysis of randomized trials. J Hypertension, 2002; 20(8):1493-99.
25. Vogel, R. A., Corretti, M. C., & Plotnick, G. D. The postprandial effect of components of the Mediterranean diet on endothelial function. Journal of American College of Cardiology, 2000; 36(5):1455-60.
26. De Lorgeril, M. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases. Subcell Biochemistry, 2007; 42:283-97.
27. Kremer, J. M., Lawrence, D. A., Petrillo, G. F., et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Arthritis Rheumotology, 1995; 38:1107-14.
28. Olsen, S. F., & Secher, N. J. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: Prospective cohort study. British Medical Journal, 2002; 324:1-5.
29. Scientific Advisory Committee on Toxicity. Advice on fish consumption: Benefits and risk. London stationery office. http://www.food.gov.uk/ multimedia/pdfs/fishreport2004. Accessed 2.9.08.
30. SanGiovanni, J. P., Berkey, C. S., Dwyer, J. T., & Colditz, G. A. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy full-term infants: A systematic review. Early Human Development, 2000; 57:165-88.
31. Helland, I. B., Smith, L., Saarem, K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics, 2003; 111:E39-E44.
32. Chong, E. W., Kreis, A. J., Wong, T. Y., Simpson, J. A., & Guymer, R. H. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. A systemic review and meta-analysis. Arch Ophthalmol, 2008; 126(6):826-33.
33. Resnikoff, S., Pascolini, D., Etya'ale, D., et al. Global data on visual impairment in the year 2002. Bull World Health Organ, 2004; 82:844-51.
34. Nguyen, C. T., Vingrys, A. J., & Bui, B. V. Dietary omega-3 fatty acids and ganglion cell function. Invest Ophthalmol Vis Sci, 2008; 49(8):3586-94.
35. Augood, C., Chakravarthy, U. & Young, I. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr., 2008; 88(2):398-406.
36. http://www.nei.nih.gov/amd/summary.asp. Accessed 9.26.08.
37. http://www.areds2.org; www.nei.nih.gov/AREDS2. Accessed 9.26.08.
38. SanGiovanni, J. P., Chew, E., Agrón, E., et al. The Relationship of Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Intake with Incident Age-Related Macular Degeneration: AREDS Report No. 23. Arch Ophthalmol, 2008; 126(9):1274-79.
39. Nguyen, C. T., Bui, B. V., Sinclair, A. J., & Vingrys, A. J. Dietary omega-3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow. Invest Ophthalmol Vis Sci, 2007; 48(2):756-62.
40. Lemp, M. A. Epidemiology and classification of dry eye. Adv Exp Med Biol, 1998; 438:791-803.
41. Goto, E., Yagi, Y., Matsumoto, Y., & Tsubota, K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol, 2002; 133:181-6.
42. Solomon, A., Dursun, D., Liu, Z., et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dryeye disease. Invest Ophthalmol Vis Sci, 2001; 42:2283-92.
43. Miljanovic, B., Komal, A. T., Dana, R., et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. American Journal of Clinical Nutrition, 2006; 82(4), 887-93.
44. Rashid, S., Jin, Y., Ecoiffier, T., et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol, 2008; 126(2):219-25.
45. http://www.nei.nih.gov/news/pressreleases/062407.asp. Retrieved: October 5, 2008.
46. Kris-Etherton, P., Harris, W., & Appel, J. W. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation, 2002; 106:2747.
47. Holub, B. J. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. Canadian Medical Association Journal, 2002; 166(5):608-15.
48. Center for Food Safety and Applied Nutrition, US Food and Drug Administration. Consumer advisory: An important message for pregnant women and women of childbearing age who may become pregnant about the risks of mercury in fish. March 2001. http://www.cfsan.fda. gov/̃dms/admehg.html. Accessed 11.2.2007.
49. Kris-Etherton, P. M., Harris, W. S., & Appel, L. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. 2002; 106(21):2747-57.